Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Converging chemistry and clinical orthopedics in the emerging role of MOFs in advanced bone defect repair

Chen Y., Liu X., Chen X., Du H., Zhou Z.

Narrative Review on Chronic Inflammation, published in Theranostics (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Theranostics (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42244997
PMCID
PMC13231978
DOI
10.7150/thno.129987

Abstract (original English)

In recent years, metal-organic frameworks (MOFs) have attracted significant attention in regenerative medicine due to their exceptional structural tunability, high surface-to-volume ratios, and controllable porosity. This review systematically outlines the versatile functions of MOFs in bone defect repair, including their use as sustained ion release systems for osteogenic metal ions ( e.g. , Sr 2+ , Zn 2+ , Mg 2+ , or Cu 2+ ), nanocarriers for controlled delivery of biomolecules ( e.g. , growth factors, drugs, or genes), and functional components within composite scaffolds to enhance mechanical and biological properties. Moreover, MOFs exhibit inherent antibacterial and anti-inflammatory properties, which are also important for bone defect repair. We critically discuss current challenges, including biostability, degradation kinetics, and long-term biosafety, and highlight perspectives on future directions, including the design and development of the smart, stimuli-responsive MOF systems for bone defect repair.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Bone and BonesAnimalsHumansDrug Delivery SystemsOrthopedicsRegenerative MedicineBone RegenerationOsteogenesisTissue ScaffoldsMetal-Organic Frameworks

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research